High production system for infectious hepatitis C virus particle

Details for Australian Patent Application No. 2006295800 (hide)

Owner Tokyo Metropolitan Organization for Medical Research Japan as represented by Director-General of National Institute of Infectious Diseases Toray Industries, Inc.

Inventors Suzuki, Ryosuke; Ishii, Koji; Wakita, Takaji; Suzuki, Tetsuro; Tanabe, JunIchi; Sone, Saburo; Miyamura, Tatsuo

Agent Davies Collison Cave

Pub. Number AU-B-2006295800

PCT Pub. Number WO2007/037428

Priority 2005-287646 30.09.05 JP

Filing date 29 September 2006

Wipo publication date 5 April 2007

Acceptance publication date 18 August 2011

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12N 7/00 (2006.01) Viruses, e.g. bacteriophages

Event Publications

8 May 2008 PCT application entered the National Phase

  PCT publication WO2007/037428 Priority application(s): WO2007/037428

18 August 2011 Application Accepted

  Published as AU-B-2006295800

20 October 2011 Alteration of Name

  The name of the applicant has been altered to Japan as represented by Director-General of National Institute of Infectious Diseases; Toray Industries, Inc.; Tokyo Metropolitan Institute of Medical Science

15 December 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006295825-Pipe joint, refrigeration device, heat pump hot water supply device, closing valve, water supply piping, method of connecting piping, and in-the-field piping method

2006295785-Agent for promoting glucagon-like peptide 1 secretion, food or drink for promoting glucagon-like peptide 1 secretion, agent for inhibiting postprandial increase in blood sugar level and food or drink for inhibiting postprandial increase in blood sugar level